- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
T2 Biosystms is a diagnostics & research business based in the US. T2 Biosystms shares (TTOO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.08 – a decrease of 22.86% over the previous week. T2 Biosystms employs 113 staff and has a trailing 12-month revenue of around $7.2 million.
What's in this guide?
- TTOO shares summary
- Compare share dealing platforms
- Is TTOO stock a buy or sell?
- Stock performance over time
- Can I short TTOO shares?
- Are TTOO shares over-valued?
- T2 Biosystms's financials
- How volatile are TTOO shares?
- Does T2 Biosystms pay a dividend?
- Have TTOO shares ever split?
- Other common questions
Our top picks for where to buy T2 Biosystms stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy T2 Biosystms stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TTOO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy T2 Biosystms stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
T2 Biosystms stock price (NASDAQ: TTOO)
Use our graph to track the performance of TTOO stocks over time.T2 Biosystms shares at a glance
Latest market close | $1.08 |
---|---|
52-week range | $1.09 - $8.38 |
50-day moving average | $2.35 |
200-day moving average | $3.93 |
Wall St. target price | $5.00 |
PE ratio | 0.0424 |
Dividend yield | N/A |
Earnings per share (TTM) | $29.70 |
Is it a good time to buy T2 Biosystms stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
T2 Biosystms price performance over time
Historical closes compared with the close of $1.08 from 2024-10-25
1 week (2024-10-18) | -22.86% |
---|---|
1 month (2024-09-27) | -46.00% |
3 months (2024-07-26) | -78.78% |
6 months (2024-04-26) | -61.97% |
1 year (2023-10-27) | -80.33% |
---|---|
2 years (2022-10-24) | -31.65% |
3 years (2021-10-27) | 34.24% |
5 years (2019-10-25) | 2.41 |
Is T2 Biosystms stock undervalued or overvalued?
Valuing T2 Biosystms stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of T2 Biosystms's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
T2 Biosystms's P/E ratio
T2 Biosystms's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, T2 Biosystms shares trade at around 0x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
T2 Biosystms financials
Revenue TTM | $7.2 million |
---|---|
Gross profit TTM | $-24,766,000 |
Return on assets TTM | -90.46% |
Return on equity TTM | -622.14% |
Profit margin | 0% |
Book value | $-0.34 |
Market Capitalization | $25.2 million |
TTM: trailing 12 months
T2 Biosystms share dividends
We're not expecting T2 Biosystms to pay a dividend over the next 12 months.
Have T2 Biosystms's shares ever split?
T2 Biosystms's shares were split on a 1:100 basis on 12 October 2023 . So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your T2 Biosystms shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for T2 Biosystms shares which in turn could have impacted T2 Biosystms's share price.
T2 Biosystms share price volatility
Over the last 12 months, T2 Biosystms's shares have ranged in value from as little as $1.09 up to $8.3799. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while T2 Biosystms's is 0.313. This would suggest that T2 Biosystms's shares are less volatile than average (for this exchange).
T2 Biosystms overview
T2 Biosystems, Inc. , an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Frequently asked questions
What percentage of T2 Biosystms is owned by insiders or institutions?Currently 4.447% of T2 Biosystms shares are held by insiders and 74.651% by institutions. How many people work for T2 Biosystms?
Latest data suggests 113 work at T2 Biosystms. When does the fiscal year end for T2 Biosystms?
T2 Biosystms's fiscal year ends in December. Where is T2 Biosystms based?
T2 Biosystms's address is: 101 Hartwell Avenue, Lexington, MA, United States, 02421 What is T2 Biosystms's ISIN number?
T2 Biosystms's international securities identification number is: US89853L1044 What is T2 Biosystms's CUSIP number?
T2 Biosystms's Committee on Uniform Securities Identification Procedures number is: 89853L104
More guides on Finder
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
Ask a question